If you've applied for the Onyx Biotec Ltd IPO,
you're likely eager to know the allocation status. Well,
the wait is over! The allotment process has been
completed, and now you can easily check how many shares
you've been allotted. You can do this by visiting the
Mas Services Limited registrar website. Moreover,
for those who didn't receive an allotment, rest assured,
the refund process has also been finalized.
The allotment date for the Onyx Biotec Ltd IPO
has been confirmed, and allotments have been finalized.
Investors who applied for the issue can now verify their
allotment status on the registrar portal designated for
Onyx Biotec Ltd IPO, managed by Mas Services Limited. You can discover the number of shares allotted
to you through the registrar's website. Additionally,
the company has concluded the refund process for
investors who were not allotted shares. The subscription
period for Onyx Biotec Ltd IPO commenced on November 13, 2024, and concluded on November 18, 2024.
On the third day of subscription, the Onyx Biotec Ltd IPO witnessed 13.61 times subscription. The listing date is
scheduled on November 21, 2024. Investors can ascertain
their share allocation through the basis of allotment
process and check their allotment status. For those who
were not allocated shares, the refund process will
commence on November 20, 2024. Those allotted shares will
receive them in their demat accounts on November 20, 2024.
The listing date for Onyx Biotec Ltd IPO is
confirmed to be November 21, 2024.
If you've applied for the Onyx Biotec Ltd IPO,
you can easily check your allotment status on the Mas Services Limited website. Here's a simple guide to
check your allotment status:
- Go to the Mas Services Limited website.
-
Select the Onyx Biotec Ltd IPO from the
dropdown menu.
-
Choose either your Application Number, Demat
Account, or PAN to proceed.
-
Select your application type as ASBA or non-ASBA.
-
Provide the required details based on your selection
in the previous step.
- Complete the Captcha verification.
-
Click on the submit button to view your allotment
status.
-
Navigate to the allotment page on the official BSE
website via this link:
https://www.bseindia.com/investors/appli_check.aspx
-
In the 'Issue Type' section, opt for 'Equity' and
pick the Onyx Biotec Ltd IPO from the
dropdown menu labeled 'Issue Name'.
-
Enter either your PAN or application number, then
click the 'Submit' button.
-
to NSE's official website using this
link:https://www.nseindia.com/
-
Choose the 'Click here to sign up' option and
complete the registration process using your PAN
details.
-
Enter your username, password, and captcha code on
the subsequent page.
-
Once logged in, navigate to the designated section
to check the IPO allotment status.
The following table outlines the allocation quotas for
different categories, detailing both the number of
shares and the percentage of the total share capital
raised. However, it's primarily the quotas for retail
and HNI investors that are of significant interest.
Category of Investors |
Allocation of shares under IPO
|
Reservation for Employees |
0 (0%) |
Anchor Allocation |
13,66,000 (28.4%) |
QIB Shares Offered |
9,12,000 (18.96%) |
NII (HNI) Shares Offered |
6,88,000 (14.3%) |
Retail Shares Offered |
16,00,000 (33.26%) |
Total Shares Offered |
48,10,000 |
Data Source: NSE-SME
Let's now examine how different categories of investors
participated in placing their bids for the IPO of Onyx Biotec Ltd.
Next, let's delve into the level of subscription. The
table below illustrates the degree of subscription for
each category, along with the overall subscription for
Onyx Biotec Ltd.
Category |
Subscription Status |
Qualified Institutional Buyers (QIB) |
0x |
S (HNI) ₹2 lakhs to ₹10 lakhs |
[-] |
B (HNI) Above ₹10 lakhs |
[-] |
Non Institutional Investors (NII) |
10.94x |
Retail Individuals |
22.92x |
Employees |
[-] |
Overall Subscription |
13.61x |
Data Source: NSE-SME
The QIB portion witnessed a
subscription of 0 times, while the HNI/NII portion
saw a subscription of 10.94 times. The Retail portion
experienced a subscription of 22.92 times, culminating in
an overall subscription of 13.61 times for the IPO.